Exploratory analysis elevates innovation in biomarker science Cross-functional teams at Merck KGaA, Darmstadt, Germany, combine subject matter expertise, clinical data analysis and exploration to pursue new oncology therapies. Recent biomarker research has led to the creation of increasingly targeted drugs and diagnostic assays. This personalized approach to health care is largely made possible by the proliferation of new tech- nologies that generate larger and more complex data sets. With access to increasingly sophisticated patient data, scientists can now investigate diagnostic and drug response questions that until recently were beyond the capabilities of available technology. The sheer quantity of data involved in pharmaceutical research has created a need for robust an

Join for free to read